HOME >> MEDICINE >> NEWS
First trimester use of ACE inhibitors implicated in birth defects

The Food and Drug Administration is examining study data from Vanderbilt University Medical Center researchers, published this week in the New England Journal of Medicine, to determine if new warnings should be placed on common blood pressure medications indicating an increased risk of birth defects for babies whose mothers take these medications during the first trimester of pregnancy.

The study, led by William Cooper, M.D., M.P.H., associate professor of Pediatrics at the Monroe Carell Jr. Children's Hospital at Vanderbilt, found infants born to mothers who took angiotensin converting enzyme inhibitors (ACE inhibitors) during the first trimester of pregnancy had an increased risk of major birth defects, compared with infants whose mothers did not take these medications.

Out of 29,507 infants whose TennCare records were examined for the study, 209 were exposed to ACE inhibitors in the first trimester only. When those babies were compared to the rest of the population, including babies exposed to other types of antihypertensive medications, they had more than double the risk of major birth defects, especially of the heart and central nervous system.

Cooper is first author on the study, which includes co-authors from the Departments of Pediatrics, Preventive Medicine and Biostatistics.

"We knew ACE inhibitors were a possible cause of adverse fetal outcomes when exposure occurred later in pregnancy, but it has not been well studied in the first trimester," Cooper said. "We were very surprised that even after controlling for other risk factors, the TennCare records we examined showed a clear increase in a broad range of birth defects following first-trimester-only exposures."

This research is important because of an increase in the number of women of childbearing age who develop high blood pressure and are prescribed ACE inhibitors. These drugs already carry a warning that they may cause injury and even death to t
'"/>

Contact: Carole Bartoo
carole.bartoo@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
7-Jun-2006


Page: 1 2

Related medicine news :

1. First of its kind report on how children with brain tumors perform at school
2. First clinical trial of gene therapy for childhood blindness
3. First nationwide child health and air pollution study commences
4. First step in developing heart hormone-based pill to control high blood pressure
5. First greenhouse gas animations produced using Envisat SCIAMACHY data
6. First ozone and nitrogen dioxide measurements from MetOp-A
7. First-degree fetal heart block may be reversible
8. 10 outstanding scientists chosen as First Environmental Health Science Fellows
9. First-time mothers at increased risk for postpartum mental disorders
10. Transforming knowledge into economic benefits -- EPSRCs First Knowledge Transfer Challenge Awards
11. First Quantum Grant to fund stem cell repair of damage from stroke

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: First trimester use ACE inhibitors implicated birth defects

(Date:10/27/2014)... CA and San Diego, CA (PRWEB) October 27, ... nurse quality indicators database, kicks off its Reliability ... at the U.S. Grant Hotel in downtown San ... experts in a dynamic exchange to advance hospital’s ... , “This year’s conference keynote speakers exemplify the ...
(Date:10/27/2014)... Jiwa Law Corporation now provides Vancouver personal ... motor vehicle accidents. The corporation now assists clients in ... up to a maximum of $150,000. These accident benefits ... medications, home support services, and medical equipment. , ... the way you live your life,” states a company ...
(Date:10/27/2014)... and Atlanta, GA (PRWEB) October 27, 2014 ... cloud-based technologies for the healthcare market, and financial ... offer a fully integrated payment and security solution ... EHR is a cloud-based online, ambulatory Electronic Health ... for small and medium-sized practices. Through the ChARM ...
(Date:10/27/2014)... HealthDay Reporter FRIDAY, Oct. 24, ... hospitals have infection control procedures in place to effectively and ... the 1,039 acute care hospitals that responded to the survey, ... percent said they were "not prepared," according to the Association ... results of the poll paint a disturbing picture, and point ...
(Date:10/27/2014)... Medicines Agency (EMA), an EU agency, has gathered information ... the European ADR database, EudraVigilance. Both authorities and pharmaceutical ... to the database, which provides new knowledge about unknown ... adverse drug reaction reports on asthma medications approved for ... period (2007 to 2011). In the light of the ...
Breaking Medicine News(10 mins):Health News:Healthcare Leaders to Address Reliability and Resiliency in Hospitals 2Health News:Jiwa Law Corporation Now Assists Clients With ICBC Claims for Motor Vehicle Accidents 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 2Health News:MedicalMine and Bluefin Payment Systems Partner for Integrated Patient Payments in the ChARM EHR Software Platform 3Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 2Health News:Few U.S. Hospitals Ready to Handle Ebola, Survey Finds 3Health News:Adverse drug reactions in children following use of asthma medications 2
(Date:10/30/2014)... 29, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, is committed to pursuing ... developed an innovative, patent-pending dual carrier transdermal delivery ... pharmaceutical active ingredients to penetrate the skin and ... The transdermal delivery method also overcomes microbial drug ...
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli ... details of its long-standing technology transfer program to increase ... Begun in 2003, the effort included Lilly donating manufacturing ... in China , India ... South Africa – all MDR-TB ,hot ...
(Date:10/27/2014)... CHICAGO , Oct. 27, 2014  Demonstrations ... and devices are being featured this week in ... 2014 Scientific Assembly where more than 7,000 emergency ... medicine and participating in educational courses. ... back drop of true-to-life emergency department environments, including ...
Breaking Medicine Technology:ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Emergency Medicine of the Future Demonstrated at ACEP14 2Emergency Medicine of the Future Demonstrated at ACEP14 3Emergency Medicine of the Future Demonstrated at ACEP14 4Emergency Medicine of the Future Demonstrated at ACEP14 5Emergency Medicine of the Future Demonstrated at ACEP14 6Emergency Medicine of the Future Demonstrated at ACEP14 7Emergency Medicine of the Future Demonstrated at ACEP14 8Emergency Medicine of the Future Demonstrated at ACEP14 9Emergency Medicine of the Future Demonstrated at ACEP14 10Emergency Medicine of the Future Demonstrated at ACEP14 11Emergency Medicine of the Future Demonstrated at ACEP14 12Emergency Medicine of the Future Demonstrated at ACEP14 13Emergency Medicine of the Future Demonstrated at ACEP14 14Emergency Medicine of the Future Demonstrated at ACEP14 15
Cached News: